161 related articles for article (PubMed ID: 37246885)
21. On the translational control of ornithine decarboxylase expression by polyamines.
Stjernborg L; Heby O; Holm I; Persson L
Biochim Biophys Acta; 1991 Oct; 1090(2):188-94. PubMed ID: 1932110
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy with 2-difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinoma.
Chen Y; Weeks RS; Burns MR; Boorman DW; Klein-Szanto A; O'Brien TG
Int J Cancer; 2006 May; 118(9):2344-9. PubMed ID: 16331620
[TBL] [Abstract][Full Text] [Related]
23. Difluoromethylornithine enhances the uptake of methylglyoxal-bis(guanylhydrazone) prior to inhibiting leukemic cell proliferation.
Maddox AM; Orengo I; Haddox MK
Chemotherapy; 1987; 33(2):110-22. PubMed ID: 3105968
[TBL] [Abstract][Full Text] [Related]
24. Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine.
Love RR; Carbone PP; Verma AK; Gilmore D; Carey P; Tutsch KD; Pomplun M; Wilding G
J Natl Cancer Inst; 1993 May; 85(9):732-7. PubMed ID: 8478959
[TBL] [Abstract][Full Text] [Related]
25. Decreased cytotoxicity of cis-diamminedichloroplatinum(II) by alpha-difluoromethylornithine depletion of polyamines in 9L rat brain tumor cells in vitro.
Oredsson SM; Deen DF; Marton LJ
Cancer Res; 1982 Apr; 42(4):1296-9. PubMed ID: 6800651
[TBL] [Abstract][Full Text] [Related]
26. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications.
Thomas T; Thomas TJ
Breast Cancer Res Treat; 1994 Feb; 29(2):189-201. PubMed ID: 8012036
[TBL] [Abstract][Full Text] [Related]
27. Alpha-difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells.
Selamnia M; Mayeur C; Robert V; Blachier F
Biochem Pharmacol; 1998 Apr; 55(8):1241-5. PubMed ID: 9719479
[TBL] [Abstract][Full Text] [Related]
28. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
[TBL] [Abstract][Full Text] [Related]
29. Increased glucose oxidation and contents of insulin and ATP in polyamine-depleted rat insulinoma cells (RINm5F).
Sjöholm A; Welsh N; Hoftiezer V; Bankston PW; Hellerström C
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):533-40. PubMed ID: 1859381
[TBL] [Abstract][Full Text] [Related]
30. Comparison and characterization of growth inhibition in L1210 cells by alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N8-bis(ethyl)spermidine, an apparent regulator of the enzyme.
Porter CW; Ganis B; Vinson T; Marton LJ; Kramer DL; Bergeron RJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6279-85. PubMed ID: 3096560
[TBL] [Abstract][Full Text] [Related]
31. Alpha-difluoromethylornithine resistance in Leishmania donovani is associated with increased ornithine decarboxylase activity.
Coons T; Hanson S; Bitonti AJ; McCann PP; Ullman B
Mol Biochem Parasitol; 1990 Feb; 39(1):77-89. PubMed ID: 2154691
[TBL] [Abstract][Full Text] [Related]
32. A quantitative proteomic screen to identify potential drug resistance mechanism in α-difluoromethylornithine (DFMO) resistant Leishmania donovani.
Singh AK; Roberts S; Ullman B; Madhubala R
J Proteomics; 2014 May; 102():44-59. PubMed ID: 24631822
[TBL] [Abstract][Full Text] [Related]
33. Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma.
Koomoa DL; Yco LP; Borsics T; Wallick CJ; Bachmann AS
Cancer Res; 2008 Dec; 68(23):9825-31. PubMed ID: 19047162
[TBL] [Abstract][Full Text] [Related]
34. Reduced cell death in skin flaps in rats treated with difluoromethylornithine.
Gelman J; Bartolome JV; Jenkins S; Serafin D; Schanberg SM; Klitzman B
FASEB J; 1987 Dec; 1(6):474-7. PubMed ID: 3119414
[TBL] [Abstract][Full Text] [Related]
35. Exploring polyamine metabolism of Alternaria alternata to target new substances to control the fungal infection.
Estiarte N; Crespo-Sempere A; Marín S; Sanchis V; Ramos AJ
Food Microbiol; 2017 Aug; 65():193-204. PubMed ID: 28400003
[TBL] [Abstract][Full Text] [Related]
36. Role of polyamine biosynthesis during gut mucosal adaptation after burn injury.
Chung DH; Evers BM; Townsend CM; Huang KF; Herndon DN; Thompson JC
Am J Surg; 1993 Jan; 165(1):144-9. PubMed ID: 8418689
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy.
Geck RC; Foley JR; Murray Stewart T; Asara JM; Casero RA; Toker A
J Biol Chem; 2020 May; 295(19):6263-6277. PubMed ID: 32139506
[TBL] [Abstract][Full Text] [Related]
38. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention.
Meyskens FL; Gerner EW; Emerson S; Pelot D; Durbin T; Doyle K; Lagerberg W
J Natl Cancer Inst; 1998 Aug; 90(16):1212-8. PubMed ID: 9719082
[TBL] [Abstract][Full Text] [Related]
39. Effects of treatments with alpha-difluoromethylornithine and hyperthermia on the growth and polyamine metabolism of Harding-Passey murine melanoma.
Lopez Ballester JA; Peñafiel R; Cremades A; Valcarcel MM; Solano F; Lozano JA
Anticancer Res; 1991; 11(2):691-6. PubMed ID: 1905904
[TBL] [Abstract][Full Text] [Related]
40. Effect of difluoromethylornithine on host and tumor polyamine metabolism during total parenteral nutrition.
Harris WB; Grossie VB; Ota DM; Nishioka K; Ajani JA; Chang T; Patenia D
J Surg Res; 1985 Jun; 38(6):592-8. PubMed ID: 3925242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
